Literature DB >> 26947772

Structural characterization of NRAS isoform 5.

Joseph Markowitz1,2, Tapas K Mal3, Chunhua Yuan3, Nicholas B Courtney2, Mitra Patel2, Andrew R Stiff2, James Blachly2, Christopher Walker2, Ann-Kathrin Eisfeld2, Albert de la Chapelle2, William E Carson2,4.   

Abstract

It was recently discovered that the NRAS isoform 5 (20 amino acids) is expressed in melanoma and results in a more aggressive cell phenotype. This novel isoform is responsible for increased phosphorylation of downstream targets such as AKT, MEK, and ERK as well as increased cellular proliferation. This structure report describes the NMR solution structure of NRAS isoform 5 to be used as a starting point to understand its biophysical interactions. The isoform is highly flexible in aqueous solution, but forms a helix-turn-coil structure in the presence of trifluoroethanol as determined by NMR and CD spectroscopy.
© 2016 The Protein Society.

Entities:  

Keywords:  NMR; NRAS; isoform; melanoma

Mesh:

Substances:

Year:  2016        PMID: 26947772      PMCID: PMC4838646          DOI: 10.1002/pro.2916

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  27 in total

1.  Automated NMR structure calculation with CYANA.

Authors:  Peter Güntert
Journal:  Methods Mol Biol       Date:  2004

Review 2.  The mechanism of alpha-helix formation by peptides.

Authors:  J M Scholtz; R L Baldwin
Journal:  Annu Rev Biophys Biomol Struct       Date:  1992

3.  NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation.

Authors:  Ann-Kathrin Eisfeld; Sebastian Schwind; Kevin W Hoag; Christopher J Walker; Sandya Liyanarachchi; Ravi Patel; Xiaomeng Huang; Joseph Markowitz; Wenrui Duan; Gregory A Otterson; William E Carson; Guido Marcucci; Clara D Bloomfield; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-28       Impact factor: 11.205

Review 4.  Indications and options for systemic therapy in melanoma.

Authors:  Vernon K Sondak; Geoffrey T Gibney
Journal:  Surg Clin North Am       Date:  2014-08-06       Impact factor: 2.741

Review 5.  Chemical shifts as a tool for structure determination.

Authors:  D S Wishart; B D Sykes
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

6.  Beneficial effects of RAF inhibitor in mutant BRAF splice variant-expressing melanoma.

Authors:  Edward J Hartsough; Kevin J Basile; Andrew E Aplin
Journal:  Mol Cancer Res       Date:  2014-02-11       Impact factor: 5.852

7.  Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitors.

Authors:  Kevin J Basile; Kaitlyn Le; Edward J Hartsough; Andrew E Aplin
Journal:  Pigment Cell Melanoma Res       Date:  2014-02-10       Impact factor: 4.693

8.  PDBStat: a universal restraint converter and restraint analysis software package for protein NMR.

Authors:  Roberto Tejero; David Snyder; Binchen Mao; James M Aramini; Gaetano T Montelione
Journal:  J Biomol NMR       Date:  2013-07-30       Impact factor: 2.835

9.  The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data.

Authors:  D S Wishart; B D Sykes
Journal:  J Biomol NMR       Date:  1994-03       Impact factor: 2.835

10.  Mechanism by which 2,2,2-trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: a molecular dynamics study.

Authors:  Danilo Roccatano; Giorgio Colombo; Marco Fioroni; Alan E Mark
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-26       Impact factor: 11.205

View more
  2 in total

1.  Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapy.

Authors:  Megan C Duggan; Kelly Regan-Fendt; Gonzalo N Olaverria Salavaggione; John Harrison Howard; Andrew R Stiff; Julia Sabella; Nicholas Latchana; Joseph Markowitz; Alejandro Gru; Susheela Tridandapani; Ann-Kathrin Eisfeld; Albert de la Chapelle; William E Carson
Journal:  Melanoma Res       Date:  2019-10       Impact factor: 3.599

Review 2.  Splice variants of RAS-translational significance.

Authors:  Erzsébet Rásó
Journal:  Cancer Metastasis Rev       Date:  2020-08-08       Impact factor: 9.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.